Donor‐Derived Engineered Microvessels for Cardiovascular Risk Stratification of Patients with Kidney Failure
Abstract
Cardiovascular disease is the cause of death in ≈50% of hemodialysis patients. Accumulation of uremic solutes in systemic circulation is thought to be a key driver of the endothelial dysfunction that underlies elevated cardiovascular events. A challenge in understanding the mechanisms relating chronic kidney disease to cardiovascular disease is the lack of in vitro models that allow screening of the effects of the uremic environment on the endothelium. Here, a method is described for microfabrication of human blood vessels from donor cells and perfused with donor serum. The resulting donor‐derived microvessels are used to quantify vascular permeability, a hallmark of endothelial dysfunction, in response to serum spiked with pathophysiological levels of indoxyl sulfate, and in response to serum from patients with chronic kidney disease and from uremic pigs. The uremic environment has pronounced effects on microvascular integrity as demonstrated by irregular cell–cell junctions and increased permeability in comparison to cell culture media and healthy serum. Moreover, the engineered microvessels demonstrate an increase in sensitivity compared to traditional 2D assays. Thus, the devices and the methods presented here have the potential to be utilized to risk stratify and to direct personalized treatments for patients with chronic kidney disease.Keywords
Funding Information
- American Heart Association (CDA857738)
- North Carolina Biotechnology Center (2021‐FLG‐3814)
- National Science Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007750)
- National Heart, Lung, and Blood Institute (F31HL162462)
- National Institute of General Medical Sciences (R35 GM142944‐01)
This publication has 62 references indexed in Scilit:
- In vitro microvessels for the study of angiogenesis and thrombosisProceedings of the National Academy of Sciences, 2012
- Endothelial DifferentiationArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Tissue Organization by Cadherin Adhesion Molecules: Dynamic Molecular and Cellular Mechanisms of Morphogenetic RegulationPhysiological Reviews, 2011
- Human Vascular Endothelial Cells: A Model System for Studying Vascular Inflammation in Diabetes and AtherosclerosisCurrent Diabetes Reports, 2011
- The Human Serum MetabolomePLOS ONE, 2011
- Aortic PWV in Chronic Kidney Disease: A CRIC Ancillary StudyAmerican Journal of Hypertension, 2010
- Endothelial actin and cell stiffness is modulated by substrate stiffness in 2D and 3DJournal of Biomechanics, 2009
- Overweight, Obesity, and the Development of Stage 3 CKD: The Framingham Heart StudyAmerican Journal of Kidney Diseases, 2008
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care OrganizationArchives of internal medicine (1960), 2004